Results indicated that only 5% of GC patients showed genetic alterations, including missense mutation, amplification, and deep deletion (Fig. 2F), which suggested the minimal influence of genetic variations on SERPINE1 expression. The gene discussed is SERPINE1; the disease is gastric cancer.